EchoGo Amyloidosis vs EchoGo Pro
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 68/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
EchoGo Amyloidosis is specifically designed for the early detection of cardiac amyloidosis by analyzing echocardiogram video clips. In contrast, EchoGo Pro automates stress echocardiography analysis to improve the diagnosis of coronary artery disease. While both are AI-powered, FDA-cleared, cloud-based solutions from Ultromics that analyze echocardiograms, they target distinct cardiac conditions and diagnostic pathways.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGo Amyloidosis is an AI-powered screening tool specifically designed to aid in the early detection of cardiac amyloidosis by analyzing echocardiogram video clips. EchoGo Pro is an AI-powered cloud solution that automates stress echocardiography analysis to improve the diagnosis of coronary artery disease.
EchoGo Amyloidosis provides a diagnostic output of 'suggestive' or 'not suggestive' of cardiac amyloidosis, with a high diagnostic accuracy of 85% sensitivity and 93% specificity, consistent across CA subtypes. EchoGo Pro automates stress echocardiography analysis to provide near-instant, comprehensive reports for coronary artery disease, aiming to improve diagnostic accuracy and reduce misdiagnosis.
For EchoGo Amyloidosis, inpatient analyses are Medicare-covered with NTAP Code ICD-10 XXE2X19 at $1,000 per analysis, and outpatient analyses use HCPCS Code C9786 at $285 per analysis, covered by Medicare and select commercial insurers. For EchoGo Pro, reimbursement codes are available for related EchoGo products, such as CPT 0932T for EchoGo Heart Failure and NTAP XXE2X19 for inpatient settings.
EchoGo Amyloidosis analyzes echocardiogram video clips, focusing on echocardiographic markers such as ventricular volume, cardiac function, and myocardial movement to identify suspected cardiac amyloidosis. EchoGo Pro automates the analysis of stress echocardiography images to identify coronary artery disease.
Both tools are cloud-based SaaS models designed for seamless integration with existing clinical workflows and IT infrastructure, including PACS, DICOM, and HL7. EchoGo Pro is specifically highlighted as a vendor-neutral system compatible with any PACS.